China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs
Beijing wants cheaper, better drugs. That’s pressuring drug makers to innovate as generics become more competitive.
Stay updated with breaking news from Research Development Association. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beijing wants cheaper, better drugs. That’s pressuring drug makers to innovate as generics become more competitive.
Explore the OECD's top-performing countries for biotech, from the U.S. powerhouse to the promising landscapes of the U.K., Belgium, and more.
Suzhou, China--(Newsfile Corp. - March 7, 2023) - The China BioMed Innovation and Investment Conference (CBIIC) is a high-end dialogue platform between the pharmaceutical industry and the investment
Domestic pharmaceutical enterprises are stepping up efforts for high-quality innovations to propel drug research and development in pursuit of high-quality growth, according to experts and business executives.
Like many others, Fei Liu found work last year in the huge new industry supporting China's fight to suppress COVID-19. But with Beijing abandoning it's COVID-zero policy, those jobs are rapidly disappearing.